// App-Quantinova.ai

P1087 : FAVEZELIMAB (ANTI–LAG-3) AND PEMBROLIZUMAB CO-BLOCKADE IN PATIENTS WITH RELAPSED OR REFRACTORY CLASSICAL HODGKIN LYMPHOMA WHO PROGRESSED AFTER ANTI–PD-1 THERAPY: AN OPEN-LABEL PHASE 1/2 STUDY

Researchers

Presenter

  • Alex F. Herrera

Principal Investigators

  • David Lavie

  • Nathalie A. Johnson

  • Abraham Avigdor

  • Peter Borchmann

  • Charalambos Andreadis

  • Ali Bazargan

  • Gareth Gregory

  • Colm Keane

  • Vladan Vucinic

  • Pier Luigi Zinzani

  • Hong Zhang

  • Patricia Marinello

  • John Timmerman

Medical Centers

  • UCLA Medical Center,Los Angeles,Verenigde Staten

  • Princess Alexandra Hospital, Brisbane, Australia

  • Co., Inc.,Kenilworth,United States

  • Princess Alexandra Hospital,Brisbane,Австралия

  • Princess Alexandra Hospital, Brisbane, Australia

  • UCLA Medical Center,Los Angeles,États-unis

  • School of Clinical Sciences, Monash University, Melbourne, Australia

  • Princess Alexandra Hospital, Brisbane, Australia

  • University of Melbourne, Melbourne, and St Vincent's Hospital,Fitzroy,Australie

  • Hadassah Medical Center, Jerusalem, Israel

  • City of Hope, Duarte, United States

  • UCLA Medical Center,Los Angeles,États-unis

  • IRCCS Azienda Ospedaliero‐Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna,Bologna,Italia

  • University of Leipzig Medical Center,Leipzig,Germania

  • UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA

  • University of Leipzig Medical Center,Leipzig,Germania

  • Co., Inc.,Kenilworth,Estados Unidos

  • UCLA Medical Center, CA

  • Princess Alexandra Hospital, Brisbane, Australia

  • UCLA Medical Center,Los Angeles,Verenigde Staten

  • Hadassah Medical Center, Jerusalem, Israel

  • Hadassah Medical Center,Jerusalem,Израиль

  • School of Clinical Sciences at Monash Health, Monash University

  • City of Hope,Duarte,États-unis

  • University Hospital of Cologne,Cologne,Германия

  • UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA

  • Jewish General Hospital, Montreal, QC, Canada

  • University Hospital of Cologne,Cologne,Allemagne

  • University of Leipzig Medical Center,Leipzig,Germania

  • UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA

  • Co., Inc.,Kenilworth,Vereinigte Staaten

  • City of Hope,Duarte, CA,Estados Unidos

  • Rabin Medical Center, Petah Tikva and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

  • IRCCS Azi

  • Co., Inc.,Kenilworth,Stati Uniti

  • University of Melbourne, Melbourne, and St Vincent's Hospital,Fitzroy,Australie

  • City of Hope,Duarte,Vereinigte Staaten

  • City of Hope,Duarte,Stati Uniti

  • University Hospital of Cologne,Cologne,Allemagne

  • Jewish General Hospital, Montreal, QC, Canada

  • Monash University School of Clinical Sciences at Monash Health, Monash University, Clayton, Australia

  • University of Leipzig Medical Center,Leipzig,Germania

  • Merck &amp

  • Univ. Hospital of Cologne, Cologne, Germany

  • Monash University School of Clinical Sciences at Monash Health, Monash University, Clayton, Australia

  • Co., Inc, Kenilworth, NJ

  • University of Leipzig Medical School, Leipzig, Germany

  • Jewish General Hospital,Montreal,Канада

  • University of Melbourne, Melbourne, and St Vincent's Hospital,Fitzroy,Australie

  • UCLA Medical Center Los Angeles CA United States

  • Rambam Health Care Campus, Haifa, Israel

  • Princess Alexandra Hospital, Brisbane, Australia

  • City of Hope,Duarte,Vereinigte Staaten

  • UCLA Medical Center,Los Angeles,Estados Unidos

  • Sheba Medical Center, Ramat Gan, and Sackler Faculty of Medicine, Tel Aviv University,Tel Avi

  • University of Leipzig Medical Center,Leipzig,Germania

  • Princess Alexandra Hospital

  • Rabin Medical Center, Petah Tikva and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

  • Hadassah Medical Center, Jerusalem, Israel

  • Rambam Health Care Campus,Haifa,Израиль

  • Co., Inc.,Kenilworth,Vereinigte Staaten

  • University of Leip

  • UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA

  • City of Hope, Duarte, CA

  • Rambam Health Care Campus, Haifa, Israel

  • Co., Inc.,Kenilworth, NJ,États-unis

  • Universit

  • University Hospital of Cologne,Cologne,Allemagne

  • Rabin Medical Center, Petah Tikva and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

  • University Hospital of Cologne,Cologne,Allemagne

  • IRCCS Azienda Ospedaliero‐Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna,Bologna,Italia

  • University Hospital of Cologne,Cologne,Allemagne

  • Jewish General Hospital, Montreal, QC, Canada

  • UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA

  • Rambam Health Care Campus, Haifa, Israel

  • University of Leipzig Medical Center,Leipzig,Germania

  • Univ. Hospital of Cologne, Cologne, Germany

Locations

  • United States

  • Israel

  • Canada

  • Germany

  • Australia

  • Italy

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Hodgkin's Lymphoma

Biomarkers

  • Programmed cell death protein 1

Drug/Treatment

  • Pembrolizumab

Outcome

  • N/A

Study Design

  • Open Label

  • Cohort

Phase

  • I/II

Study Id's

  • NCT03598608

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved